New research shows AHSCT was superior to cladribine and alemtuzumab in reducing relapses in people with relapsing remitting MS.

A new international study found children with MS who started highly effective treatment before age 18 had less disability in early adulthood than those starting later.

Researchers have found that children and young people with childhood-onset MS ate more ultra-processed foods than same-aged people without MS.

New research shows that in people with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), smoking is associated with relapse rates more than twice that of those who had never smoked.

New research finds an online mental health treatment program provides long term improvements in depression and anxiety in people with MS.

A new study using tissue from brain banks has shed light on the brain’s clean up processes and how these impact brain repair in MS.